Amount Raised
$15 Million
Round Type
Series A
CambridgeBiotechnologyInvestors
Description
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures (DvH Ventures). As part of the round, Yoann Bonnamour, Mérieux Equity Partners, and Arnaud Autret, Illumina Ventures, join the Company’s Board of Directors.
Quick answer
Broken String Biosciences raised $15 Million in a Series A round, dated September 18, 2023. Investors: Arnaud Autret, Yoann Bonnamour, Dieter Von Holtzbrinck Ventures, Tencent, Heran Partners, Mérieux Equity Partners and Illumina Ventures. Broken String Biosciences is based in Cambridge, Massachusetts, United States.
- How much did Broken String Biosciences raise?
- Broken String Biosciences raised $15 Million in a Series A round on September 18, 2023.
- Who invested in Broken String Biosciences?
- Arnaud Autret, Yoann Bonnamour, Dieter Von Holtzbrinck Ventures, Tencent, Heran Partners, Mérieux Equity Partners and Illumina Ventures are named as investors in this round.
- What does Broken String Biosciences do?
- Broken String Biosciences is advancing more precise, safe, and effective cell and gene therapies through its cutting-edge technology platforms.
- Where is Broken String Biosciences based and how big is it?
- Broken String Biosciences is based in Cambridge, Massachusetts, United States. Fundz records about 26 employees.
- Who are the decision-makers at Broken String Biosciences?
- Fundz holds 1 contact at Broken String Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Broken String Biosciences that raised within 45 days of this round, from Fundz verified event records.
- HeartBeat.bio raised $4.8M (Seed) on November 2, 2023.
- Rein Therapeutics, Inc. raised $18M on November 2, 2023.
- Genezen raised $19M (Private Equity) on November 2, 2023.
- Stellaromics raised $25M (Series A) on November 2, 2023.
- Greenbrook TMS raised $2M (Seed) on November 2, 2023.
- Phylos raised $150K (Seed) on November 1, 2023.
Who to call at Broken String Biosciences, and when
A new round usually means Broken String Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Broken String Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Broken String Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Broken String Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Broken String Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBroken String Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.